Stephen Quake
Director · AbCellera Biologics Inc.
Individual
- 2026
- Jun 12, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Stephen Quake files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael R. Hayden - $1.05M in ABCL purchases and sales in the last 12 months
- Thermopylae Holdings Ltd. - $711K in ABCL purchases and sales in the last 12 months
- Andrew Booth - $530K in ABCL purchases and sales in the last 12 months
- John S. Montalbano - $384K in ABCL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stephen Quake?
Stephen Quake is a corporate insider, tracked as Director of AbCellera Biologics Inc. (ABCL). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Stephen Quake last file a Form 4?
The only primary Form 4 on record is dated 12 June 2026.